Crystal Adam
SEC CIK 1825445 · EDGAR
BoughtSold
Most active insiders at TNGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRV GP IV, LLC | 10% | — | $8.86M |
| 2 | Crystal Adam | Pres, R, D | — | $6.33M |
| 3 | Weber Barbara | Dir, Executive COB | — | $374.4K |
| 4 | Beckman Daniella | CFO | — | $126.6K |
| 5 | Ketchum John B | Dir | — | — |
| 6 | Peters Malte | Pres, CEO, Dir | — | — |
| 7 | Rothenberg Mace | Dir | — | — |
| 8 | Gall Matthew | CFO | — | — |
| 9 | Lee Sung | Dir | — | — |
| 10 | Calhoun Lesley Ann | Dir | — | — |
Transactions 40
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-03 16:01 | 2026-09-01 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | M - OptEx | $5.20 | +27.0K | 142.7K | +23% | +$140.4K |
| DT | 2026-09-03 16:01 | 2026-09-01 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | S - Sale+OE | $22.37 | -27.0K | 115.7K | -19% | -$603.9K |
| DT | 2026-08-05 16:01 | 2026-08-03 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | M - OptEx | $5.20 | +27.0K | 142.7K | +23% | +$140.4K |
| DMT | 2026-08-05 16:01 | 2026-08-03 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | S - Sale+OE | $27.24 | -27.0K | 115.7K | -19% | -$735.5K |
| DT | 2026-07-02 19:23 | 2026-07-01 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | M - OptEx | $5.20 | +27.0K | 142.7K | +23% | +$140.4K |
| DMT | 2026-07-02 19:23 | 2026-07-01 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | S - Sale+OE | $29.59 | -27.0K | 115.7K | -19% | -$798.9K |
| DT | 2026-06-03 18:37 | 2026-06-01 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | M - OptEx | $5.20 | +27.0K | 142.7K | +23% | +$140.4K |
| DMT | 2026-06-03 18:37 | 2026-06-01 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | S - Sale+OE | $22.87 | -27.0K | 115.7K | -19% | -$617.6K |
| DT | 2026-05-05 19:47 | 2026-05-01 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | M - OptEx | $5.20 | +27.0K | 142.7K | +23% | +$140.4K |
| DMT | 2026-05-05 19:47 | 2026-05-01 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | S - Sale+OE | $21.23 | -27.0K | 115.7K | -19% | -$573.1K |
| DT | 2026-04-16 20:14 | 2026-04-15 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | M - OptEx | $5.20 | +38.5K | 151.1K | +34% | +$200.0K |
| DT | 2026-04-16 20:14 | 2026-04-15 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | S - Sale+OE | $25.00 | -38.5K | 112.6K | -25% | -$961.5K |
| DT | 2026-04-02 20:09 | 2026-04-01 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | M - OptEx | $5.20 | +27.0K | 139.6K | +24% | +$140.4K |
| DT | 2026-04-02 20:09 | 2026-04-01 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | S - Sale+OE | $21.20 | -27.0K | 112.6K | -19% | -$572.5K |
| DT | 2026-03-27 | 2026-03-25 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | M - OptEx | $5.20 | +12.0K | 124.6K | +11% | +$62.4K |
| DT | 2026-03-27 | 2026-03-25 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | S - Sale+OE | $20.11 | -12.0K | 112.6K | -10% | -$241.3K |
| T | 2026-03-09 | 2026-03-05 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | S - Sale | $15.00 | -20.3K | 112.6K | -15% | -$303.8K |
| T | 2026-02-27 | 2026-02-25 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | S - Sale | $12.77 | -54.3K | 132.9K | -29% | -$694.0K |
| DM | 2026-02-04 | 2026-02-03 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | S - Sale | $12.27 | -18.5K | 187.4K | -9% | -$226.4K |
| D | 2026-02-04 | 2026-02-02 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Pres, R, D | A - Grant | $0.00 | +47.5K | 205.7K | +30% | $0 |
| M | 2025-02-06 | 2025-02-04+ | TNGX | Tango Therapeutics, Inc. | Crystal Adam | See Remarks | S - Sale | $3.07 | -14.3K | 165.1K | -8% | -$43.9K |
| D | 2025-02-05 | 2025-02-03 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | See Remarks | A - Grant | $0.00 | +53.0K | 172.5K | +44% | $0 |
| M | 2024-02-08 | 2024-02-06+ | TNGX | Tango Therapeutics, Inc. | Crystal Adam | See Remarks | S - Sale | $12.59 | -8,371 | 119.5K | -7% | -$105.4K |
| D | 2024-02-05 | 2024-02-01 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | See Remarks | A - Grant | $0.00 | +46.6K | 46.6K | New | $0 |
| 2023-11-02 | 2023-11-01 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | See Remarks | S - Sale | $8.39 | -7,507 | 81.2K | -8% | -$63.0K | |
| D | 2023-03-02 | 2023-03-01 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | See Remarks | A - Grant | $0.00 | +81.2K | 81.2K | New | $0 |
| D | 2023-02-01 | 2023-01-30 | CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Off | M - OptEx | — | +3,750 | 21.4K | +21% | — |
| D | 2023-02-01 | 2023-01-30 | CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Off | F - Tax | $7.78 | -1,301 | 20.1K | -6% | -$10.1K |
| A | 2022-06-14 | 2022-05-26 | CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Off | F - Tax | $7.01 | -1,102 | 17.6K | -6% | -$7,725 |
| D | 2022-05-27 | 2022-05-25 | CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Off | M - OptEx | — | +3,750 | 18.8K | +25% | — |
| D | 2022-01-05 | 2022-01-04 | CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Off | M - OptEx | $6.49 | +15.0K | 30.0K | +100% | +$97.3K |
| DM | 2022-01-05 | 2022-01-04 | CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Off | S - Sale+OE | $31.67 | -15.0K | 16.1K | -48% | -$475.0K |
| D | 2021-12-23 | 2021-12-22 | CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Off | M - OptEx | $6.49 | +5,000 | 15.0K | +50% | +$32.5K |
| D | 2021-10-12 | 2021-10-08 | CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Off | M - OptEx | $6.49 | +10.0K | 10.0K | New | +$64.9K |
| DM | 2021-10-05 | 2021-10-01 | CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Off | S - Sale+OE | $45.43 | -15.0K | 0 | -100% | -$681.4K |
| D | 2021-10-05 | 2021-10-01 | CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Off | M - OptEx | $4.98 | +15.0K | 15.0K | New | +$74.7K |
| D | 2021-08-02 | 2021-07-29 | CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Off | S - Sale+OE | $45.00 | -15.0K | 0 | -100% | -$675.0K |
| D | 2021-08-02 | 2021-07-29 | CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Off | M - OptEx | $4.98 | +15.0K | 15.0K | New | +$74.7K |
| DM | 2021-07-06 | 2021-07-01 | CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Off | S - Sale+OE | $37.98 | -15.0K | 1,700 | -90% | -$569.7K |
| D | 2021-07-06 | 2021-07-01 | CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Off | M - OptEx | $6.50 | +15.0K | 15.0K | New | +$97.5K |
Purchase Sale Sale after option exercise All abbreviations